Gotu Kola Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Gotu Kola dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Gotu Kola.
Dosing Protocols
Beginner Gotu Kola protocol (0-12 weeks). Start with a single well-characterized, third-party-tested Centella asiatica extract standardized to at least 10% asiaticoside or 40% total triterpenes. Dose 250 mg once daily with breakfast for the first 7 days to assess tolerance and screen for idiosyncratic GI upset or allergic reactions. If tolerated, increase to 250 mg twice daily (with breakfast and lunch) for weeks 2-4. By week 4, you should have a stable baseline and can assess whether you want to remain at 500 mg/day total or advance further. For the majority of beginners seeking general cognitive, stress-resilience, and skin-quality support, 500 mg/day of standardized extract is a sensible long-term dose and does not require aggressive cycling. For beginners focused specifically on venous or microvascular symptoms (heaviness, ankle edema, mild varicosities), increase to 60-120 mg of TECA (total triterpene fraction) twice daily — this is the standard European pharmaceutical dose range and corresponds to roughly 600-1200 mg of 10% standardized extract. Track objective markers where possible: before-and-after photos of affected skin areas or varicose veins, simple self-report anxiety and sleep scores on a 1-10 scale captured weekly, and if you have access, a basic comprehensive metabolic panel (CMP) at baseline and week 8 to confirm normal liver enzymes. Time of day: morning and early afternoon is ideal. Avoid taking Gotu Kola within 4 hours of bedtime initially, since a subset of users experience mild activation or dream intensification at higher doses. Take with food to minimize GI upset and to maximize triterpene absorption (the saponins are moderately lipophilic). Avoid combining with alcohol during the initial 4 weeks, and avoid combining with other new supplements during this same window — you need a clean signal to assess whether Gotu Kola is doing anything for you. For topical beginners, a 5-10% Centella cream or a Korean-style cica serum applied twice daily to the face, scars, or stretch marks is a reasonable starting regimen; expect visible improvements in erythema and skin texture at 4-8 weeks and improvements in scar pliability at 8-12 weeks. Do not combine high-concentration topical retinoids with high-concentration topical Gotu Kola during the first 2 weeks of retinoid use, since cumulative irritation can occur. The beginner protocol is designed to produce a clear answer to the question "does Gotu Kola help me?" within 12 weeks. If you see no measurable benefit at 12 weeks despite consistent dosing, either the dose is too low (advance to intermediate protocol) or this particular herb is not the right tool for your case.
Intermediate Gotu Kola protocol (weeks 12-52, or for users with a specific clinical target). The intermediate protocol assumes you have confirmed individual tolerance at the beginner level and are now pursuing a more defined therapeutic goal: cognitive performance at a work-relevant level, clinically meaningful improvement in chronic venous insufficiency, active scar or wound remodeling, or generalized anxiety management. Dose: 500 mg twice daily of standardized extract (at least 10% asiaticoside or 40% total triterpenes), totaling 1000 mg/day. For venous indications, use the European pharmaceutical-style TECA dose of 60-120 mg twice daily (pure triterpene fraction, not raw leaf extract). Timing: morning with breakfast and midday with lunch. Consistency matters more than perfect timing — the tissue-remodeling effects build over weeks. Cycle: 8 weeks on, 2 weeks off, is a defensible pattern for reducing any cumulative hepatotoxicity risk and allowing downstream receptor systems to re-baseline. Alternatively, 12 weeks on, 3 weeks off, is commonly used in Ayurvedic practice. Monitoring: obtain a comprehensive metabolic panel including AST, ALT, alkaline phosphatase, and total bilirubin at baseline, week 12, and then every 6 months for long-term users. Discontinue immediately and consult a physician if any of these values rise more than 2x the upper limit of normal. At the intermediate stage, consider pairing Gotu Kola with a well-chosen stack based on your primary goal. For cognitive performance: add Bacopa monnieri 300-600 mg/day for 12-week cycles, alongside phosphatidylserine 100-300 mg/day, omega-3 2-3 g/day of EPA+DHA, and consistent sleep (7-9 hours). For venous and microvascular: add horse chestnut seed extract (aescin 50-75 mg twice daily), diosmin + hesperidin (500 mg twice daily), and a topical Centella cream applied twice daily to affected limbs. For skin and scar: add oral collagen peptides 10-20 g/day, vitamin C 500-1000 mg twice daily, zinc 15-30 mg/day, and topical GHK-Cu or tripeptide copper products twice daily. For anxiety and stress: add Ashwagandha KSM-66 or Sensoril 300-600 mg/day, L-Theanine 200 mg twice daily, and magnesium glycinate 200-400 mg at night. Topical intermediate protocol: use a higher-concentration centelloid-rich serum (10-20% Centella extract or a prescription-strength Madecassol-style product where available) applied twice daily, layered under a broad-spectrum SPF during the day and under a richer moisturizer at night. Assess clinical response at weeks 12, 24, and 36 using objective measures: standardized cognitive tests, pedometer or actigraphy data for activity, before-and-after photographs, validated anxiety or stress scales (GAD-7, PSS-10), or ultrasound-measured venous reflux time for vascular patients. The intermediate protocol is the level at which most of the published clinical trial doses sit, so if you are going to replicate a study result, this is where to do it.
Advanced Gotu Kola protocol (year 2+, clinical or condition-focused use). The advanced protocol is for users pursuing a specific clinical indication — moderate-to-severe chronic venous insufficiency, post-surgical or radiation-induced scar revision, scleroderma or other fibrotic skin disorders, significant diabetic microangiopathy, or long-term cognitive-resilience programs layered into a broader longevity regimen. Dose: for venous and microvascular indications, 120-180 mg of TECA (pure triterpene fraction) twice daily is supported by the Incandela, Pointel, and Cesarone trials, and this represents the upper end of well-studied clinical dosing. For cognitive and anxiolytic indications, 1000-2000 mg/day of standardized leaf extract divided into two or three doses has been used in clinical trials with acceptable safety. For scleroderma and fibrotic skin conditions, TECA at 60-120 mg three times daily for 6-12 months is the classical regimen used in Italian and French clinical practice. At these doses, monitoring becomes non-optional: baseline, 6-week, 12-week, and then every-3-month comprehensive metabolic panels with hepatic function, plus condition-appropriate objective measures (Doppler ultrasound venous reflux, high-resolution skin ultrasound for dermal thickness in scleroderma, neuropsychological battery for cognitive endpoints, GAD-7 and PSS-10 for anxiety endpoints). Cycling is mandatory at this dose level: 6-8 weeks on, 2 weeks off, is the standard pattern, and extended continuous use beyond 12 weeks without a break is not supported by the current safety data. Advanced users should maintain a detailed log of all concomitant medications and supplements, since polypharmacy interactions become more relevant at higher triterpene exposures. Avoid concurrent use of other known hepatotoxic agents — chaparral, comfrey, kava at high doses, germander, certain Chinese herbal combinations of unclear provenance, and unregulated "liver detox" products. Advanced stacking at this level should be medically supervised when possible. For scleroderma patients, TECA is often layered with low-dose methotrexate, calcium channel blockers for Raynaud's, and careful attention to pulmonary and renal function. For diabetic microangiopathy patients, TECA pairs with tight glycemic control, blood pressure management, ACE inhibition, statins as indicated, and careful foot care. For cognitive longevity programs, the advanced Gotu Kola protocol typically sits inside a larger multi-botanical regimen that includes Bacopa, Lion's Mane, Rhodiola, Ashwagandha, and omega-3, with periodic reassessment of cognitive performance, inflammatory markers (hs-CRP, IL-6), and liver function. A final advanced consideration is intermittent high-dose acute use for specific events — for example, a single high dose (1-2 g of leaf or equivalent extract) used for the peri-operative period to support wound healing in the 48 hours before and the first 2 weeks after a planned surgical procedure. This approach is extrapolated from mechanistic data on TGF-beta and collagen synthesis timelines and has not been validated in controlled trials, so it should be considered exploratory. The advanced protocol is inherently more risk-laden than the beginner or intermediate levels, and the risk-benefit calculation changes once you are dosing at TECA 360 mg/day and above — this is the territory where the rare hepatotoxicity reports have occurred, and medical oversight is strongly recommended.
Commonly Stacked With
Gotu Kola is one of the most flexibly stackable adaptogens because its effects are distributed across tissue types rather than concentrated in a single pathway — it layers cleanly on top of cognitive stacks, skin and anti-aging stacks, and vascular and venous-health stacks without meaningful pharmacodynamic collisions. The most classical and most evidence-supported stack is with Bacopa monnieri, the other "Brahmi." In traditional Ayurvedic formulations, Mandukaparni (Gotu Kola) and Brahmi (Bacopa) were paired in the original medhya rasayana combination alongside Yashtimadhu (licorice), Guduchi, and Shankhapushpi. The rationale is mechanistically sound — Bacopa contributes cholinergic modulation and hippocampal dendritic arborization, while Gotu Kola contributes BDNF upregulation, GABAergic modulation, and vascular perfusion enhancement. Users running a focused cognitive stack typically dose 300-600 mg of Bacopa (standardized to 20-55% bacosides) alongside 500-1000 mg of Gotu Kola (standardized to 10-40% asiaticoside), both taken with meals for 8-12 weeks minimum. The combination is particularly useful for people with both cognitive complaints and anxiety, since Bacopa's anxiolytic effect is mild and Gotu Kola reinforces it. A second excellent cognitive stack is Gotu Kola with Lion's Mane mushroom for BDNF and NGF co-modulation — Lion's Mane drives NGF via hericenones and erinacines, Gotu Kola drives BDNF via triterpenes, and the combination addresses both peripheral and central nerve growth factor signaling. Add phosphatidylserine at 100-300 mg/day for cortisol modulation and membrane fluidity, and you have a complete cognitive-resilience stack for long-term daily use. For vascular and venous health, Gotu Kola pairs classically with Hawthorn (Crataegus species) for combined microvascular and macrovascular support. Hawthorn provides coronary and systemic vasodilation through its flavonoid and oligomeric proanthocyanidin content, while Gotu Kola works at the venous wall and capillary level. Users with chronic venous insufficiency, varicose veins, or post-phlebitic syndrome often benefit from adding horse chestnut seed extract (aescin 50-75 mg twice daily), butcher's broom, and diosmin + hesperidin (500 mg twice daily) to this base. Topically, micronized Gotu Kola cream applied twice daily to affected limbs complements the oral regimen. For skin and wound healing, the gold-standard stack combines oral Gotu Kola (500-1000 mg/day of standardized extract) with topical applications of both Gotu Kola cream and a copper-peptide product such as GHK-Cu. GHK-Cu and Gotu Kola operate through different but synergistic mechanisms — GHK-Cu promotes fibroblast chemotaxis and extracellular matrix remodeling through copper-dependent enzyme activation, while Gotu Kola's triterpenes drive TGF-beta-Smad-mediated collagen synthesis. Add oral vitamin C at 500-1000 mg twice daily (critical for collagen hydroxylation), zinc at 15-30 mg/day, and collagen peptides at 10-20 g/day, and you have a complete connective-tissue stack for post-surgical recovery, chronic wound care, scar revision, or skin-aging support. For anxiety and stress, Gotu Kola layers well with Ashwagandha (KSM-66 or Sensoril, 300-600 mg/day), L-Theanine (200-400 mg as needed), and magnesium glycinate (200-400 mg at night). Gotu Kola's GABAergic tone complements Ashwagandha's cortisol-modulating effect and L-Theanine's alpha-wave enhancement. For people using this stack for chronic anxiety rather than acute use, 8-12 weeks is the realistic timescale for seeing meaningful effects. Gotu Kola also layers cleanly with Rhodiola rosea for stress resilience (Rhodiola is stimulating, Gotu Kola is calming — the combination produces alert-calm focus), with Tulsi / Holy Basil for cortisol rhythm and inflammation, and with Reishi for immune and sleep support. For skin-focused users interested in Korean-style cica regimens, combining oral Gotu Kola with topical centella serums, niacinamide 5% serum, azelaic acid, and retinol creates a barrier-repair and anti-inflammatory skincare stack that is particularly effective for rosacea, post-acne erythema, and sensitive skin. Avoid stacking Gotu Kola with high-dose concentrated extracts of other potentially hepatotoxic herbs (comfrey, chaparral, germander, kava at very high doses), and be cautious about stacking with multiple sedating botanicals at once (Gotu Kola + kava + valerian + high-dose ashwagandha + magnesium + alcohol is a recipe for excessive sedation). When in doubt, start with one new herb at a time, maintain a 2-week observation window for each addition, and keep total daily triterpene exposure from all sources under a reasonable ceiling. Finally, consider cycling: many traditional Ayurvedic practitioners recommended 6-8 week Gotu Kola cycles followed by 1-2 week breaks, and the small but real hepatotoxicity signal in the modern literature supports this pattern for high-dose concentrated extracts.
Side Effects & Safety
Contraindications
Gotu Kola should be avoided or used only under medical supervision in the following populations and situations. Pregnancy: traditional and precautionary contraindication; animal data shows uterine stimulation and possible teratogenicity at high doses, and oral supplementation should be avoided. Breastfeeding: safety data is essentially absent, and the herb should be avoided while nursing as a precaution. Pre-existing liver disease: hepatitis, cirrhosis, fatty liver disease, and other conditions with elevated baseline liver enzymes are relative contraindications given the rare but documented idiosyncratic hepatotoxicity signal with concentrated oral extracts. Heavy alcohol use: additive hepatotoxicity risk — users consuming more than 14 drinks per week should avoid high-dose concentrated extracts. Concomitant use of hepatotoxic medications: methotrexate, isoniazid, acetaminophen at high doses, certain statins at high doses, amiodarone, and other known hepatotoxic agents should not be combined with high-dose Gotu Kola without medical supervision and periodic liver enzyme monitoring. Scheduled surgery: discontinue 2 weeks before elective surgery to minimize any theoretical bleeding risk and to simplify post-operative liver enzyme interpretation. Active bleeding disorders or anticoagulant therapy (warfarin, direct oral anticoagulants, antiplatelet drugs): use caution and avoid high doses; no clinically significant bleeding events have been reported at standard doses, but the interaction is theoretically possible. Diabetes with insulin or sulfonylurea therapy: monitor blood glucose closely when starting or adjusting Gotu Kola dose, since mild hypoglycemic effects have been reported. Seizure disorders: no clear contraindication, but the GABAergic activity could theoretically lower seizure threshold in sensitive individuals, so use with caution and maintain consistent dosing with anticonvulsants. Children under 18: no standard pediatric dosing exists and supplemental use should be under pediatric medical supervision; topical use for specific dermatologic indications is occasionally practiced but should be medically guided. Known allergy to Centella asiatica or to other Apiaceae family plants (carrot, celery, parsley, coriander, fennel, dill): avoid due to cross-reactivity risk. Skin cancer history on affected areas: use topical Gotu Kola cautiously on areas of prior skin malignancy, since the fibroblast-stimulating and pro-angiogenic effects could theoretically support tumor regrowth, although no clinical evidence of this exists in humans. Contact dermatitis or allergic reaction to previous Centella products: discontinue and avoid further exposure. Concurrent use of other sedating substances: Gotu Kola has mild GABAergic and sedative effects that can be additive with benzodiazepines, opioids, barbiturates, sedative antihistamines, alcohol, kava, and high-dose valerian. Avoid driving or operating machinery until you understand your individual response. Gotu Kola should also be avoided during periods of acute febrile illness or active infection, since the immunomodulatory and fibroblast-stimulating effects could theoretically interact with the acute inflammatory response; resume after recovery. For autoimmune conditions, particularly those involving skin fibrosis (scleroderma, morphea) or vasculitis, Gotu Kola has a plausible rationale but should be integrated into the care plan in consultation with a rheumatologist or dermatologist rather than used as monotherapy. Finally, people pursuing aggressive "hardcore" nootropic stacks containing multiple unregulated research chemicals should be cautious about layering Gotu Kola into a regimen where hepatotoxicity signals would be difficult to attribute to a single agent — a clean, simple baseline with periodic liver function monitoring is the safer approach for long-term use.
Additional Notes
Gotu Kola dosage depends on the indication and the specific preparation, which is a critical detail because triterpene content varies enormously between preparations. For general cognitive, stress, and skin-quality support, 500-1000 mg/day of a standardized extract (at least 10% asiaticoside or 40% total triterpenes) divided into one or two doses is a well-supported starting range. For chronic venous insufficiency and microangiopathy, the clinically validated dose is 60-180 mg/day of TECA (total triterpene fraction, a much more concentrated preparation) divided into two to three doses. For anxiolytic or acute pre-event anxiety use, Bradwejn's original trial used a single 12-gram oral dose of raw leaf, which is far higher than typical supplemental doses and is not practical for daily use; for chronic anxiety, 500-1000 mg/day of standardized extract for 4-8 weeks is more practical. For scar and wound-healing applications, both oral (500-1000 mg/day of standardized extract) and topical (5-20% Centella creams applied twice daily) are commonly used in combination. Take oral Gotu Kola with food to improve triterpene absorption and minimize GI upset — the saponins are moderately lipophilic and benefit from dietary fat. Morning and early afternoon dosing is preferred; avoid within 4 hours of bedtime for the first 2 weeks of use due to possible mild activation or dream intensification, although for many users bedtime dosing is fine after initial acclimation. Cycle long-term use: 6-8 weeks on, 2 weeks off, is the standard conservative pattern supported by current safety data; 12 weeks on, 3 weeks off, is an alternative. Do not exceed 2000 mg/day of standardized extract or 360 mg/day of TECA without medical supervision. For topical use, a 5-10% Centella cream or serum applied twice daily is a reasonable starting regimen for facial skin; higher concentrations (10-20%) and prescription-strength products like Madecassol can be used for scar revision, post-surgical wound care, and more aggressive dermatologic indications. Layer topical Gotu Kola under broad-spectrum SPF during the day and under a richer moisturizer at night; do not combine high-concentration Gotu Kola with freshly initiated high-concentration retinoids for the first 2 weeks, since cumulative irritation can occur. For pediatric use, standard dosing recommendations do not exist and the herb should only be used in children under direct pediatric medical supervision. For geriatric use, start at half the adult dose and titrate based on tolerance, since liver and renal clearance may be reduced. For pregnancy and breastfeeding, oral Gotu Kola is contraindicated; topical use is generally discouraged on broken skin and should be discussed with an obstetric provider if considered for mild cosmetic or dermatologic indications on intact skin for limited durations. Missed doses: take as soon as remembered unless it is close to the next scheduled dose, in which case skip. Do not double-dose to compensate. Finally, product quality matters enormously. Prefer products that publish standardized triterpene content, specify country of origin, and provide third-party testing for heavy metals and microbial contamination. TECA preparations from European pharmaceutical manufacturers (Madecassol, Centellase) are the gold standard for vascular indications; for over-the-counter supplements, reputable brands with USP, NSF, or equivalent third-party certifications are the safer choice.
Frequently Asked Questions
What is the recommended Gotu Kola dosage?
Dosage for Gotu Kola varies by protocol. Consult a qualified healthcare provider.
How often should I take Gotu Kola?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Gotu Kola need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Gotu Kola side effects?
Gotu Kola has an excellent overall safety profile — one of the best in the botanical adaptogen category — but there are several caveats that long-term users and high-dose users need to understand. The most commonly reported side effects are mild and predictable: transient gastrointestinal upset (nausea, loose stools, mild cramping) in the first week of oral use, especially with concentrated extracts taken on an empty stomach; mild headache in approximately 5-10% of users; and rare drowsiness or sedation at doses above 1500 mg/day of standardized extract. The bitter taste of whole-leaf preparations can be unpleasant, and some users experience a mildly metallic aftertaste from capsule formulations. Topically, Gotu Kola is extremely well tolerated but can cause contact dermatitis in approximately 1% of users, usually presenting as localized erythema, itching, or a mild eczematous reaction within 24-72 hours of application. The most serious safety issue — and the one that has received disproportionate attention in regulatory discussions — is idiosyncratic hepatotoxicity. A small number of case reports, mostly from Europe, have documented elevated liver enzymes and, in rare cases, clinically significant hepatitis associated with Centella asiatica use, almost exclusively with high-dose concentrated oral extracts taken for extended periods. The mechanism is not well understood, and the causality is often confounded by concomitant medication use, pre-existing liver disease, or herbal product contamination. The absolute risk appears very low — well under 1 per 10,000 users based on post-marketing surveillance data from regulated pharmaceutical products — but the French ANSM and some other regulatory bodies have advised limiting continuous oral use to 6 weeks followed by a 2-week break as a precautionary measure. Users with pre-existing liver disease, heavy alcohol use, or concomitant hepatotoxic medication use (acetaminophen, methotrexate, isoniazid, some statins at high doses) should avoid Gotu Kola or use it only under medical supervision with periodic liver enzyme monitoring. Pregnancy is a well-established traditional contraindication. Animal studies have shown uterine-stimulating effects and potential teratogenicity at high doses, and while there is no direct evidence of fetal harm in humans at typical supplemental doses, the herb should be avoided during pregnancy unless used topically on unbroken skin for a limited duration and in consultation with an obstetric provider. Breastfeeding data is essentially absent, and Gotu Kola should generally be avoided while nursing. Drug-interaction concerns include: mild additive sedation when combined with benzodiazepines, sedative antihistamines, opioids, alcohol, or GABAergic herbs like valerian and kava; theoretical interaction with anticoagulants (warfarin, direct oral anticoagulants) and antiplatelet drugs (aspirin, clopidogrel), although no clinically significant bleeding events have been reported at standard doses; possible interaction with diabetes medications, since Gotu Kola may have mild hypoglycemic effects and could potentiate insulin or sulfonylureas; and theoretical interaction with hepatically metabolized drugs, particularly at high doses, though CYP450 studies at standard doses have not shown clinically meaningful inhibition. Stopping Gotu Kola before elective surgery is a reasonable precaution — most surgical teams recommend discontinuation 2 weeks before surgery to minimize any theoretical bleeding risk and to simplify post-operative liver enzyme interpretation. Children should not use Gotu Kola orally without pediatric clinical guidance; topical pediatric use for specific indications is occasionally practiced but should be under medical supervision. People with a history of skin cancer should use topical Gotu Kola cautiously on affected areas, since the fibroblast-stimulating and pro-angiogenic effects could theoretically support tumor growth, although there is no clinical evidence of this in humans. Finally, product quality is a meaningful safety variable. Unlike peptides, where synthesis quality dominates, Gotu Kola is an agricultural product, and its phytochemical profile varies significantly with growing region (Madagascar, India, Sri Lanka, Indonesia, and China all produce commercial crops), soil composition, harvest timing, and post-harvest processing. Adulteration with unrelated Centella species, contamination with heavy metals (especially cadmium and lead in some Asian sources), and inclusion of irrelevant plant parts have all been documented. Buying from manufacturers who publish standardized triterpene content (typically 10-40% asiaticoside or total triterpenes) and third-party contaminant testing substantially reduces these risks.
Where can I buy Gotu Kola?
Visit our vendor directory to find trusted sources for Gotu Kola.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
